Future perspectives on swine viral vaccines: where are we headed?
Abstract Deliberate infection of humans with smallpox, also known as variolation, was a common practice in Asia and dates back to the fifteenth century. The world’s first human vaccination was administered in 1796 by Edward Jenner, a British physician. One of the first pig vaccines, which targeted t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-01-01
|
| Series: | Porcine Health Management |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40813-020-00179-7 |
| _version_ | 1818452918269902848 |
|---|---|
| author | Tanja Opriessnig Ashley A. Mattei Anbu K. Karuppannan Patrick G. Halbur |
| author_facet | Tanja Opriessnig Ashley A. Mattei Anbu K. Karuppannan Patrick G. Halbur |
| author_sort | Tanja Opriessnig |
| collection | DOAJ |
| description | Abstract Deliberate infection of humans with smallpox, also known as variolation, was a common practice in Asia and dates back to the fifteenth century. The world’s first human vaccination was administered in 1796 by Edward Jenner, a British physician. One of the first pig vaccines, which targeted the bacterium Erysipelothrix rhusiopathiae, was introduced in 1883 in France by Louis Pasteur. Since then vaccination has become an essential part of pig production, and viral vaccines in particular are essential tools for pig producers and veterinarians to manage pig herd health. Traditionally, viral vaccines for pigs are either based on attenuated-live virus strains or inactivated viral antigens. With the advent of genomic sequencing and molecular engineering, novel vaccine strategies and tools, including subunit and nucleic acid vaccines, became available and are being increasingly used in pigs. This review aims to summarize recent trends and technologies available for the production and use of vaccines targeting pig viruses. |
| first_indexed | 2024-12-14T21:30:43Z |
| format | Article |
| id | doaj.art-1c37188d6a2a4050b0bb56656a8d36ba |
| institution | Directory Open Access Journal |
| issn | 2055-5660 |
| language | English |
| last_indexed | 2024-12-14T21:30:43Z |
| publishDate | 2021-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Porcine Health Management |
| spelling | doaj.art-1c37188d6a2a4050b0bb56656a8d36ba2022-12-21T22:46:42ZengBMCPorcine Health Management2055-56602021-01-017111610.1186/s40813-020-00179-7Future perspectives on swine viral vaccines: where are we headed?Tanja Opriessnig0Ashley A. Mattei1Anbu K. Karuppannan2Patrick G. Halbur3The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of EdinburghThe Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of EdinburghVaccine Research Centre-Viral Vaccines, Centre for Animal Health Studies, Tamil Nadu Veterinary and Animal Sciences UniversityDepartment of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State UniversityAbstract Deliberate infection of humans with smallpox, also known as variolation, was a common practice in Asia and dates back to the fifteenth century. The world’s first human vaccination was administered in 1796 by Edward Jenner, a British physician. One of the first pig vaccines, which targeted the bacterium Erysipelothrix rhusiopathiae, was introduced in 1883 in France by Louis Pasteur. Since then vaccination has become an essential part of pig production, and viral vaccines in particular are essential tools for pig producers and veterinarians to manage pig herd health. Traditionally, viral vaccines for pigs are either based on attenuated-live virus strains or inactivated viral antigens. With the advent of genomic sequencing and molecular engineering, novel vaccine strategies and tools, including subunit and nucleic acid vaccines, became available and are being increasingly used in pigs. This review aims to summarize recent trends and technologies available for the production and use of vaccines targeting pig viruses.https://doi.org/10.1186/s40813-020-00179-7VaccinesReviewViruses, pigs |
| spellingShingle | Tanja Opriessnig Ashley A. Mattei Anbu K. Karuppannan Patrick G. Halbur Future perspectives on swine viral vaccines: where are we headed? Porcine Health Management Vaccines Review Viruses, pigs |
| title | Future perspectives on swine viral vaccines: where are we headed? |
| title_full | Future perspectives on swine viral vaccines: where are we headed? |
| title_fullStr | Future perspectives on swine viral vaccines: where are we headed? |
| title_full_unstemmed | Future perspectives on swine viral vaccines: where are we headed? |
| title_short | Future perspectives on swine viral vaccines: where are we headed? |
| title_sort | future perspectives on swine viral vaccines where are we headed |
| topic | Vaccines Review Viruses, pigs |
| url | https://doi.org/10.1186/s40813-020-00179-7 |
| work_keys_str_mv | AT tanjaopriessnig futureperspectivesonswineviralvaccineswhereareweheaded AT ashleyamattei futureperspectivesonswineviralvaccineswhereareweheaded AT anbukkaruppannan futureperspectivesonswineviralvaccineswhereareweheaded AT patrickghalbur futureperspectivesonswineviralvaccineswhereareweheaded |